VHL Enhances 9-cis-Retinoic Acid Treatment by Down-Regulating Retinoid X Receptor α in RCCs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Biochemical and Biophysical Research Communications
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
VHL Enhances 9-cis-Retinoic Acid Treatment by Down-Regulating Retinoid X Receptor α in Renal Cell Carcinomas
Biochem. Biophys. Res. Commun 2020 Jan 09;[EPub Ahead of Print], F Wang, LS Wang, YH Gao, XD YaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.